Tokyo - Delayed Quote JPY
MedRx Co., Ltd (4586.T)
64.00
0.00
(0.00%)
At close: 3:30:00 PM GMT+9
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
254,049
--
59,482
8,350
115,092
Cost of Revenue
--
--
2,619
2,263
3,913
Gross Profit
254,049
--
56,862
6,086
111,179
Operating Expense
844,602
--
1,155,682
1,067,312
1,241,599
Operating Income
-590,553
--
-1,098,820
-1,061,226
-1,130,420
Net Non Operating Interest Income Expense
-4,438
--
-1,866
-4,944
-5,364
Pretax Income
-513,684
--
-1,109,313
-1,058,474
-1,106,567
Tax Provision
-1,735
--
1,837
1,358
8,078
Net Income Common Stockholders
-511,948
--
-1,111,150
-1,059,833
-1,114,645
Diluted NI Available to Com Stockholders
-511,948
--
-1,111,150
-1,059,833
-1,114,645
Basic EPS
-13.36
-26.82
-43.81
-49.62
-68.61
Diluted EPS
-13.36
-26.82
-43.81
-49.62
-68.61
Basic Average Shares
38,881.50
34,777.60
25,363.47
21,357.52
16,245.13
Diluted Average Shares
40,366.10
34,777.60
25,363.47
21,357.52
16,245.13
Total Operating Income as Reported
-590,552
--
-1,098,820
-1,061,226
-1,130,420
Total Expenses
844,602
--
1,158,301
1,069,575
1,245,512
Net Income from Continuing & Discontinued Operation
-511,948
--
-1,111,150
-1,059,833
-1,114,645
Normalized Income
-533,183.03
--
-1,111,602.35
-1,065,366.75
-1,146,534.82
Interest Income
22
--
17
13
112
Interest Expense
--
--
--
1,473
367
Net Interest Income
-4,438
--
-1,866
-4,944
-5,364
EBIT
-590,553
--
-1,098,820
-1,057,001
-1,106,200
EBITDA
-545,546
--
-1,052,402
-996,665
-1,050,356
Reconciled Cost of Revenue
--
--
2,619
2,263
3,913
Reconciled Depreciation
45,007
--
46,418
60,336
55,844
Net Income from Continuing Operation Net Minority Interest
-511,948
--
-1,111,150
-1,059,833
-1,114,645
Total Unusual Items Excluding Goodwill
21,307
--
589
7,976
45,964
Total Unusual Items
21,307
--
589
7,976
45,964
Normalized EBITDA
-566,853
--
-1,052,991
-1,004,641
-1,096,320
Tax Rate for Calcs
0
--
0
0
0
Tax Effect of Unusual Items
71.97
--
136.65
2,442.25
14,074.18
12/31/2020 - 2/14/2013
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade